FDA authorizes new antibody drug to fight omicron
it clears the Eli Lilly drug for adults and adolescent patients with mild-to-moderate cases of COVID-19. |!| Portland
it clears the Eli Lilly drug for adults and adolescent patients with mild-to-moderate cases of COVID-19. |!| Portland